| Target Price | €9.95 |
| Price | €7.70 |
| Potential |
29.16%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Terveystalo 2027 .
The average Terveystalo target price is €9.95.
This is
29.16%
register free of charge
€10.50
36.36%
register free of charge
€7.68
0.31%
register free of charge
|
|
| A rating was issued by 12 analysts: 10 Analysts recommend Terveystalo to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Terveystalo stock has an average upside potential 2027 of
29.16%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion € | 1.28 | 1.24 |
| 4.56% | 2.73% | |
| EBITDA Margin | 18.55% | 18.24% |
| 11.80% | 1.66% | |
| Net Margin | 7.48% | 7.32% |
| 39.70% | 2.08% |
7 Analysts have issued a sales forecast Terveystalo 2026 . The average Terveystalo sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Terveystalo EBITDA forecast 2026. The average Terveystalo EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Terveystalo Analysts have issued a net profit forecast 2026. The average Terveystalo net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.75 | 0.72 |
| 31.58% | 4.00% | |
| P/E | 10.72 | |
| EV/Sales | 1.23 |
7 Analysts have issued a Terveystalo forecast for earnings per share. The average Terveystalo EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


